文献速递泌尿生殖腹部MR

前列腺MRI报告对临床决策的影响:泌尿外科视角

Prostate MRI reporting and its impact on clinical decision-making: the urologists' perspective.
PubMed 文献 · Abdom Radiol (NY) · 2026-09-10

本综述围绕前列腺mpMRI报告的五个关键领域展开,包括活检前分诊、前列腺体积与PSAD、局部分期、淋巴结评估及主动监测的PRECISE v2随访。证据综合了截至2026年3月的随机对照试验、大队列研究、荟萃分析及临床实践指南,并优先采纳欧洲泌尿外科学会现行指南。核心观点是前列腺MRI的临床价值不仅取决于图像质量与判读准确性,也同等依赖于报告的完整性与标准化。

要点

  • 报告应纳入PI-RADS评分与PI-QUAL评估以支持活检前分诊。
  • 前列腺体积和PSAD对活检决策和风险分层有直接影响。
  • 局部分期需重点报告包膜外侵犯和精囊侵犯。

核心结论

  • 前列腺MRI的临床价值取决于完整、标准化的报告,其重要性不亚于图像采集和判读质量。
  • 报告内容直接影响活检前分诊、局部分期、淋巴结评估和主动监测等临床决策环节。

研究设计与样本

  • 本综述综合了截至2026年3月发表的随机对照试验、大队列研究、荟萃分析和临床实践指南证据。
  • 证据优先采纳最高级别可用证据及欧洲泌尿外科学会现行指南的推荐意见。

关键影像表现/征象

  • 报告应涵盖PI-RADS评分和PI-QUAL评估所对应的前列腺MRI影像特征,以支持活检前分诊。
  • 局部分期需重点描述包膜外侵犯和精囊侵犯的相关影像征象。
  • 区域淋巴结评估需要报告与淋巴结转移风险相关的影像表现。

诊断标准与关键数值

  • 活检前分诊领域采用PI-RADS评分系统进行风险分层,并用PI-QUAL评估图像质量。
  • 前列腺体积测量与PSAD报告对临床风险判断有直接影响。
  • 局部MRI监测推荐采用PRECISE v2框架对主动监测患者进行序列评估。

临床应用与阅片要点

  • 放射科医师应在前列腺MRI报告中标准化纳入五个关键领域的内容,以支持泌尿外科的临床决策。
  • 报告PI-RADS评分时应同时关注PI-QUAL,避免因图像质量不足导致误判。
  • 主动监测场景下应按照PRECISE v2框架描述MRI序列变化,以指导后续管理策略。

局限性

  • 本综述为叙述性证据综合,未报告系统性检索策略及纳入文献的具体数量。
  • 证据优先级由作者根据现有最高级别证据主观判断,未给出正式的分级方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Multiparametric MRI (mpMRI) has fundamentally changed the diagnostic and management pathways for prostate cancer (PCa). Its clinical utility depends not only on image quality and interpretative accuracy but also on the completeness and precision of the radiological report. This review synthesizes the available evidence across five key reporting domains that directly impact clinical decision-making: (1) pre-biopsy triage, including Prostate Imaging Reporting and Data System (PI-RADS) scoring and Prostate Imaging Quality (PI-QUAL) assessment; (2) prostate volume measurement and PSA density (PSAD) reporting; (3) local staging, with particular emphasis on extraprostatic extension (EPE) and seminal vesicle invasion (SVI); (4) regional lymph node assessment, and (5) serial MRI monitoring using the PRECISE v2 framework for men undergoing active surveillance. Evidence from randomised controlled trials, large cohort studies, meta-analyses, and clinical practice guidelines published up to March 2026 was synthesised, with priority given to the highest level of available evidence and current European Association of Urology guidance. For each domain, we define the core reporting elements and discuss the evidence supporting their clinical relevance from both radiological and urological perspectives. Across all five domains, the clinical value of prostate MRI depends as much on complete and standardised reporting as on the quality of image acquisition and interpretation.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Erden, Tantekin, Gharehmohammadlou, et al. Prostate MRI reporting and its impact on clinical decision-making: the urologists' perspective. Abdom Radiol (NY). 2026. PMID: 42720765. doi:10.1007/s00261-026-05780-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。